NO20042870L - Kombinasjon av en selektiv PDE4-inhibitor og en adrenerg beta-2-reseptorantagonist - Google Patents

Kombinasjon av en selektiv PDE4-inhibitor og en adrenerg beta-2-reseptorantagonist

Info

Publication number
NO20042870L
NO20042870L NO20042870A NO20042870A NO20042870L NO 20042870 L NO20042870 L NO 20042870L NO 20042870 A NO20042870 A NO 20042870A NO 20042870 A NO20042870 A NO 20042870A NO 20042870 L NO20042870 L NO 20042870L
Authority
NO
Norway
Prior art keywords
combination
receptor antagonist
pde4 inhibitor
adrenergic beta
selective pde4
Prior art date
Application number
NO20042870A
Other languages
English (en)
Norwegian (no)
Inventor
Michael Yeadon
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO20042870L publication Critical patent/NO20042870L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
NO20042870A 2001-12-07 2004-07-06 Kombinasjon av en selektiv PDE4-inhibitor og en adrenerg beta-2-reseptorantagonist NO20042870L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0129395.0A GB0129395D0 (en) 2001-12-07 2001-12-07 Pharmaceutical combination
PCT/IB2002/004922 WO2003047578A1 (en) 2001-12-07 2002-11-22 Combination of a selective pde4 inhibitor and an adrenergic beta-2 receptor agonist

Publications (1)

Publication Number Publication Date
NO20042870L true NO20042870L (no) 2004-07-06

Family

ID=9927247

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042870A NO20042870L (no) 2001-12-07 2004-07-06 Kombinasjon av en selektiv PDE4-inhibitor og en adrenerg beta-2-reseptorantagonist

Country Status (33)

Country Link
US (2) US20030119862A1 (is)
EP (1) EP1455783A1 (is)
JP (1) JP2005511657A (is)
KR (1) KR20050044699A (is)
CN (1) CN1599609A (is)
AP (1) AP2004003054A0 (is)
AR (1) AR037712A1 (is)
AU (1) AU2002353255A1 (is)
BR (1) BR0214776A (is)
CA (1) CA2468676A1 (is)
CO (1) CO5590899A2 (is)
EA (1) EA200400640A1 (is)
EC (1) ECSP045142A (is)
GB (1) GB0129395D0 (is)
HN (1) HN2002000356A (is)
HR (1) HRP20040515A2 (is)
HU (1) HUP0402546A3 (is)
IL (1) IL162098A0 (is)
IS (1) IS7277A (is)
MA (1) MA27152A1 (is)
MX (1) MXPA04004930A (is)
NO (1) NO20042870L (is)
NZ (1) NZ533030A (is)
OA (1) OA12736A (is)
PA (1) PA8560601A1 (is)
PE (1) PE20031066A1 (is)
PL (1) PL370770A1 (is)
SV (1) SV2004001430A (is)
TN (1) TNSN04102A1 (is)
TW (1) TWI242433B (is)
UY (1) UY27564A1 (is)
WO (1) WO2003047578A1 (is)
ZA (1) ZA200403905B (is)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
DE10360954B3 (de) * 2003-12-23 2005-08-18 Esparma Gmbh Verwendung von Silibinin, dessen Salzen und/oder dessen Prodrugs zusammen mit α-Liponsäure zur Behandlung chronisch obstruktiver Lungenerkrankungen
WO2012098495A1 (en) * 2011-01-19 2012-07-26 Glenmark Pharmaceuticals Sa Pharmaceutical composition that includes revamilast and a beta-2 agonist

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039408A1 (en) * 1995-06-06 1996-12-12 Pfizer Inc. TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO[3,4-c]-1,2,4-TRIAZOLO[4,3-α]PYRIDINES
EP1107747A4 (en) * 1998-08-26 2003-04-23 Smithkline Beecham Corp COMPOSITIONS FOR THE TREATMENT OF PULMONARY DISEASES
PT1212089E (pt) * 1999-08-21 2006-08-31 Altana Pharma Ag Combinacao sinergica de roflumilast e salmeterol

Also Published As

Publication number Publication date
US20030119862A1 (en) 2003-06-26
JP2005511657A (ja) 2005-04-28
ZA200403905B (en) 2005-06-22
ECSP045142A (es) 2004-07-23
TNSN04102A1 (fr) 2006-06-01
PL370770A1 (en) 2005-05-30
AP2004003054A0 (en) 2004-06-30
TW200300678A (en) 2003-06-16
SV2004001430A (es) 2004-02-24
NZ533030A (en) 2007-03-30
EA200400640A1 (ru) 2004-12-30
EP1455783A1 (en) 2004-09-15
CO5590899A2 (es) 2005-12-30
MXPA04004930A (es) 2005-04-08
HN2002000356A (es) 2003-02-21
AU2002353255A1 (en) 2003-06-17
KR20050044699A (ko) 2005-05-12
BR0214776A (pt) 2004-11-09
CN1599609A (zh) 2005-03-23
HRP20040515A2 (en) 2004-10-31
CA2468676A1 (en) 2003-06-12
TWI242433B (en) 2005-11-01
AR037712A1 (es) 2004-12-01
WO2003047578A1 (en) 2003-06-12
IL162098A0 (en) 2005-11-20
IS7277A (is) 2004-05-21
US20040167153A1 (en) 2004-08-26
UY27564A1 (es) 2003-07-31
PA8560601A1 (es) 2005-02-04
PE20031066A1 (es) 2003-12-24
GB0129395D0 (en) 2002-01-30
MA27152A1 (fr) 2005-01-03
HUP0402546A2 (hu) 2005-04-28
HUP0402546A3 (en) 2008-04-28
OA12736A (en) 2006-06-29

Similar Documents

Publication Publication Date Title
IS7041A (is) 5-HT viðtakabindlar og notkun þeirra
ITTO20030268A1 (it) Apparecchiatura e procedimento di alesatura a
DE60103974D1 (de) Gyrase-inhibitoren und ihre verwendung
MXPA03006260A (es) Derivados de amina sustituidos y metodos de uso.
NO20020225L (no) Ekspanderbare anordninger
NO20032668D0 (no) Gyraseinhibitorer og anvendelser derav
NO20021195L (no) Rörfört fraktureringsverktöy og fremgangsmåte
NO20040248L (no) Blandede metallocenkatalysatorsystemer som inneholder en darlig komonomerinkorporering og en god konomoneringkorporering
DE60235270D1 (de) Rückschaltungsvorrichtung und Rückschaltungsverfahren
NO20024075D0 (no) Borefluid, anordning og fremgangsmåte
DE60238229D1 (de) Sendevorrichtung und sendeverfahren
NO20024732D0 (no) Ny kombinasjon av en betablokker og et kolesterolsenkende middel
NO20023843D0 (no) Skumanordning og fremgangsmåte
NO20042870L (no) Kombinasjon av en selektiv PDE4-inhibitor og en adrenerg beta-2-reseptorantagonist
DE60223540D1 (de) Mundschutz und mundschutzfolie
NO20031997L (no) CRF-reseptor-antagonist og metoder relatert dertil
IS2536B (is) Lyfjablanda úr PDE4 eða PDE3/4 tálma og histamínviðtakamótlyfi
NO20021669L (no) Fluidfylt borerörsplugg
NO20023144D0 (no) Kompleks omfattende OCIF og polysakkarid
PT1448566E (pt) Antagonistas do receptor quimioquina e metodos de utilizacao do mesmo
NO20040479L (no) Solvater av lerkanidipinhydroklorid og nye krystallinske former av lerkanidipinhydroklorid.
DE60222015D1 (de) Ccr-3-rezeptorantagonisten vii
DE60231278D1 (de) Schäumbare Bohrflüssigkeit
SE0102737D0 (sv) Fluid displacement and fluid valve using expandable microspheres
NO20035319D0 (no) En G-proteinkoblet reseptor og anvendelse derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application